Recent News

• 12.02.2025 - Science 37 Honored for Site Innovation in the 2025 Clinical Trials Arena Excellence Awards
• 12.02.2025 - Science 37 Receives 2025 Clinical Trials Arena Site Innovation Award for R&D Leadership
• 10.08.2025 - Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial
• 09.04.2025 - Science 37 and Catalent Announce Partnership Enabling Universal Access to Clinical Research

Recent Filings

• 03.25.2024 - 15-12G 15-12G
• 03.14.2024 - EFFECT EFFECT
• 03.14.2024 - 3/A Initial statement of beneficial ownership of securities
• 03.14.2024 - EFFECT EFFECT
• 03.14.2024 - SC 13D/A General Statement of Acquisition of Beneficial Ownership
• 03.14.2024 - 4 Statement of changes in beneficial ownership of securities
• 03.14.2024 - 4 Statement of changes in beneficial ownership of securities
• 03.13.2024 - SC 13D/A SC 13D/A
• 03.13.2024 - 4 4
• 03.13.2024 - 4 4